Lymphocyte signalling: A coordinating role for Vav?

Current Biology

Volumn 8, Issue 15, 1998, Pages

  Cantrell, Doreen ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0032537743     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0960-9822(07)00341-7     Document Type: Review

References (15)

1. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR: Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 1997, 385:169-172.
2. Han J, Das B, Wei W, van Aelst L, Mosteller RD, Khosravi-Far R, Westwick JK, Channing JD, Broek D: Lck regulates Vav activation of members of the Rho family of GTPases. Mol Cell Biol 1997, 17:1346-1353.
3. Collins TL, Deckert M, Altman A: Views on Vav. Immunol Today 1997, 18:221-225.
4. Nunes J, Truneh A, Olive D, Cantrell DA: Signal transduction by CD28 ligands B7-1 and B7-2: CD28 regulation of tyrosine kinase adapter molecules. J Biol Chem 1996, 251:1591-1598.
5. Tuosto L, Michel F, Acuto O: p95vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells. J Exp Med 1996, 184:1161-1166.
6. Han J, Luby-Phelps K, Das K, Shu X, Xia Y, Mosteller RD, Krishna UM, Falck JR, White MA, Broek D: Role of substrates and products of PI3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 1998, 279:558-560.
7. Wu J, Zhao Q, Kurosaki T, Weiss A: The Vav binding site (Y315) in ZAP-70 is critical for antigen receptor-mediated signal transduction. J Exp Med 1997, 185:1877-1882.
8. O'Rourke LM, Tooze R, Turner M, Sandoval DM, Carter RH, Tybulewicz VLJ, Fearon DT: CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 1998, 8:635-645.
9. Turner M, Mee PJ, Walters AE, Quinn ME, Mellor AL, Zamoyska R, Tybulewicz V: A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 1997, 7:451-460.
10. Fischer K-D, Kong Y-Y, Nishina H, Tedford K, Marengere LEM, Kozieradzki I, Sasaki T, Starr M, Chan G, Gardener S, et al.: Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr Biol 1998, 8:554-562.
11. Holsinger LJ, Graef IA, Swat W, Chi T, Bautista DM, Davidson L, Lewis RS, Alt FW, Crabtree GR: Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr Biol 1998, 8:563-572.
12. Wange RL, Samelson LE: Complex complexes - signaling at the TCR. Immunity 1996, 5:197-205.
13. Olson MF, Pasteris NG, Gorski JL, Hal A: Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases. Curr Biol 1996, 6:1628-1633.
14. Genot E, Cleverley S, Henning S, Cantrell DA: Multiple p21 ras effector pathways regulate nuclear factor of activated T cells. EMBO J 1996, 15:3923-3933.
15. Turner H, Mckenzie E, Kirchem A, Lennard D, Cantrell D: Rac-1 controls a critical commitment step for FcεR1 regulated NFAT1 nuclear import in mast cells. J Exp Med 1998, 188:in press.